BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19618072)

  • 21. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
    Rada EM; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
    [No Abstract]   [Full Text] [Related]  

  • 22. Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.
    Mizoguti Dde F; Hungria EM; Freitas AA; Oliveira RM; Cardoso LP; Costa MB; Sousa AL; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):914-20. PubMed ID: 26560982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for ML Flow seropositivity in leprosy patients.
    Grossi MA; Leboeuf MA; Andrade AR; Bührer-Sékula S; Antunes CM
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():39-44. PubMed ID: 19618074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
    Lefford MJ; Hunegnaw M; Siwik E
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate.
    Duthie MS; Raychaudhuri R; Tutterrow YL; Misquith A; Bowman J; Casey A; Balagon MF; Maghanoy A; Beltran-Alzate JC; Romero-Alzate M; Cardona-Castro N; Reed SG
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):233-9. PubMed ID: 24666703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
    Parkash O; Girdhar BK
    Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-I antibodies detected by ELISA and "dipstick" methods.
    Roche PW; Failbus SS; Britton WJ; Cole R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):279-86. PubMed ID: 10575407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ML dipstick as a tool to classify leprosy patients.
    Buhrer-Sekula S; Sarno EN; Oskam L; Koop S; Wichers I; Nery JA; Vieira LM; de Matos HJ; Faber WR; Klatser PR
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):456-63. PubMed ID: 11332289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the ML Flow serologic test to slit skin smear.
    Lyon S; Castorina da Silva R; Lyon AC; Grossi MA; Lyon SH; Azevedo Mde L; Bührer-Sékula S; Rocha MO
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():23-6. PubMed ID: 19618071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is PGL-1 also present in Leishmania donovani promastigotes?
    Gupta PN; Pal NK
    Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.
    Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S
    J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Borderline lepromatous leprosy].
    El Morabite K; Tbatou F; Ait Ourhroui M; Senouci K; Hassam B
    Presse Med; 2014 Jun; 43(6 Pt 1):733-4. PubMed ID: 24703733
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary syphilis mimicking borderline (BL) leprosy.
    Sehgal VN; Lal S; Jain S; Bhattacharya SN; Thappa DM; Logani KB
    J Dermatol; 1993 Feb; 20(2):102-4. PubMed ID: 8478483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macular lesions in leprosy: a clinical, bacteriological and histopathological study.
    Sarkar R; Kaur I; Das A; Sharma VK
    J Dermatol; 1999 Sep; 26(9):569-76. PubMed ID: 10535251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of protein antigens for early serological diagnosis of leprosy.
    Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
    Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.